Advanced company searchLink opens in new window

ONCOBONE THERAPEUTICS LTD

Company number 13249925

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
04 Oct 2024 AD01 Registered office address changed from Smith House George Street Nailsworth Stroud GL6 0AG England to 10 Queen Street Place London EC4R 1AG on 4 October 2024
04 Sep 2024 CERTNM Company name changed oncobone ventures LIMITED\certificate issued on 04/09/24
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2024-09-02
16 May 2024 AP01 Appointment of Ms Lorenza Maria Castellon as a director on 4 May 2024
03 May 2024 AA Micro company accounts made up to 31 December 2023
03 May 2024 CS01 Confirmation statement made on 22 April 2024 with updates
03 May 2024 TM01 Termination of appointment of Tarquin David Fletcher Edwards as a director on 22 April 2024
03 May 2024 TM01 Termination of appointment of Andrew Peter King as a director on 22 April 2024
18 Sep 2023 AA Micro company accounts made up to 31 December 2022
05 Jun 2023 CH01 Director's details changed for Mr Tarquin David Fletcher Edwards on 30 May 2023
05 Jun 2023 CH01 Director's details changed for Dr Tiina Emilia Kahkonen on 30 May 2023
05 Jun 2023 CH01 Director's details changed for Dr Jussi Marko Juhani Halleen on 30 May 2023
23 May 2023 CH01 Director's details changed for Dr Jussi Marko Juhani Halleen on 12 May 2023
02 May 2023 CS01 Confirmation statement made on 22 April 2023 with updates
28 Apr 2023 TM01 Termination of appointment of Satu Vainikka as a director on 19 April 2023
28 Apr 2023 AP01 Appointment of Mr Andrew Peter King as a director on 19 April 2023
23 Mar 2023 AA01 Previous accounting period shortened from 31 March 2023 to 31 December 2022
15 Nov 2022 AA Micro company accounts made up to 31 March 2022
27 Jun 2022 SH02 Sub-division of shares on 16 May 2022
22 Apr 2022 CS01 Confirmation statement made on 22 April 2022 with updates
22 Apr 2022 SH01 Statement of capital following an allotment of shares on 27 June 2021
  • GBP 8,004
18 Jun 2021 PSC08 Notification of a person with significant control statement
18 Jun 2021 CS01 Confirmation statement made on 18 June 2021 with updates
18 Jun 2021 PSC07 Cessation of Satu Vainikka as a person with significant control on 16 June 2021
18 Jun 2021 PSC07 Cessation of Tarquin David Fletcher Edwards as a person with significant control on 16 June 2021
17 Jun 2021 SH01 Statement of capital following an allotment of shares on 16 June 2021
  • GBP 4